0 Comments
0 Shares
69 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Palliative vs. Disease-Modifying: Understanding the Shift in the Neurodegenerative Disease Market Segment StrategyThe pharmaceutical industry is currently navigating a major strategic pivot. For nearly thirty years, the "gold standard" for Alzheimer’s was symptomatic treatment—drugs that improved memory for a few months but didn't stop the brain from shrinking. In 2026, the market has split into two distinct segments: traditional palliative care and the high-growth "Disease-Modifying Drugs"...0 Comments 0 Shares 78 Views 0 Reviews